WILSON TROY EDWARD 4
4 · Avidity Biosciences, Inc. · Filed Sep 9, 2025
Insider Transaction Report
Form 4
WILSON TROY EDWARD
Director
Transactions
- Sale
Common Stock
2025-09-05$50.00/sh−14,500$725,000→ 69,425 total - Sale
Common Stock
2025-09-05$50.00/sh−15,000$750,000→ 54,425 total - Exercise/Conversion
Common Stock
2025-09-05$12.48/sh+14,500$180,960→ 83,925 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-09-05−14,500→ 0 totalExercise: $12.48Exp: 2033-06-14→ Common Stock (14,500 underlying)
Holdings
- 13,711(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]All exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on December 4, 2024.
- [F2]The option is fully vested and exercisable as of the date hereof.